Here, we show that an IL-4-mediated decrease in overall ceramide levels was significantly stimulated in human KC following N-palmitoyl serinol (PS), an analog of the endocannabinoid N-palmitoyl ethanolamine, through increased activities of ceramide synthetic enzymes. The gene discussed is IL4; the disease is keratoconus.